Companies / Chinook Therapeutics, Inc.
Chinook Therapeutics, Inc.
KDNYCIK 1435049
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Nov 15, 2021 | Akkaraju Srinivas Director | Buy Open-market buy | Common Stock | $17.01M | +1.2M +35.98% | 4,591,888 | high |
| Jan 3, 2022 | Versant Venture Capital VII, L.P. 10% owner | Sell Open-market sale | Common Stock | $9.60M | -600K -14.21% | 3,623,023 | medium |
| Jan 3, 2022 | Jerel Davis Director | Sell Open-market sale | Common Stock | $9.60M | -600K -14.21% | 3,623,023 | medium |
| May 27, 2022 | Akkaraju Srinivas Director | Buy Open-market buy | Common Stock | $7.98M | +570K +12.41% | 5,161,888 | high |
| Aug 27, 2021 | Jerel Davis Director | Sell Open-market sale | Common Stock | $7.14M | -510K -10.78% | 4,223,023 | medium |
| Aug 27, 2021 | Versant Venture Capital VII, L.P. 10% owner | Sell Open-market sale | Common Stock | $7.14M | -510K -10.78% | 4,223,023 | medium |
| Apr 17, 2023 | Jerel Davis Director | Sell Open-market sale | Common Stock | $6.14M | -296K -40.00% | 443,713 | medium |
| Mar 1, 2023 | Jerel Davis Director | Sell Open-market sale | Common Stock | $5.46M | -240K -10.23% | 2,105,107 | medium |